Discontinuation report HUMALOG

Last updated on 2024-04-04 History
Report ID 224347
Drug Identification Number 02229704
Brand name HUMALOG
Common or Proper name insulin lispro injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size Vial VL7533, 3 mL, 100 units/mL
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-09-11
Actual discontinuation date
Remaining supply date 2024-09-11
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Only the 3 mL vial presentation (Vial VL7533, 3 mL, 100 units/mL) is being discontinued, anticipated remaining supply date may be impacted based on any changes in demand. The following presentations remain available: Humalog 10 mL, 100 units/mL, Vial VL7510 (same DIN 02229704), Humalog 3.0 mL, 100 units /mL, 5 cartridges/box VL7516 (DIN 02229705), Humalog 3.0 mL prefilled pen, 100 units/mL, KwikPen HP8799 (DIN 02403412), Humalog 3.0 mL prefilled pen, 100 units/mL, Junior KwikPen HP7714 (DIN 02470152)
Company comments Humalog 3 mL vial presentation shares a DIN with the 10 mL vial presentation (02229704). Humalog 10 mL vial presentation will continue to be available. For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-04-04 French Compare
v1 2024-04-04 English Compare

Showing 1 to 2 of 2